Deepika Jalota is Chief Development Officer of PMV Pharmaceuticals, Inc.. Currently has a direct ownership of 118,283 shares of PMVP, which is worth approximately $185,704. The most recent transaction as insider was on Sep 11, 2024, when has been sold 7,218 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $10,827. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
5.75% 3M change
294.99% 12M change
Total Value Held $185,704

Deepika Jalota Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2024
SELL
Open market or private sale
$10,827 $1.5 p/Share
7,218 Reduced 5.75%
118,283 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
95,555 Added 43.23%
125,501 Common Stock
Sep 15 2023
SELL
Open market or private sale
$27,168 $6.62 p/Share
4,104 Reduced 12.05%
29,946 Common Stock
Sep 09 2022
BUY
Grant, award, or other acquisition
-
34,050 Added 50.0%
34,050 Common Stock
Aug 17 2021
SELL
Open market or private sale
$97,827 $33.78 p/Share
2,896 Reduced 100.0%
0 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$10,223 $3.53 p/Share
2,896 Added 50.0%
2,896 Common Stock
DJ

Deepika Jalota

Chief Development Officer
Cranbury, NJ

Track Institutional and Insider Activities on PMVP

Follow PMV Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMVP shares.

Notify only if

Insider Trading

Get notified when an Pmv Pharmaceuticals, Inc. insider buys or sells PMVP shares.

Notify only if

News

Receive news related to PMV Pharmaceuticals, Inc.

Track Activities on PMVP